Human medicines European public assessment report (EPAR): Nepexto, etanercept, Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Spondylarthropathies;Spondylitis, Ankylosing;Psoriasis, Date of authorisation: 20/05/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Sezary Syndrome;Mycosis Fungoides, Date of authorisation: 22/11/2018, Revision: 6, Status: Authorised

Responses to list of issues - GFR slope as a Surrogate Endpoint in RCT for CKD

DRAFT qualification opinion for GFR slope as a Surrogate Endpoint in RCT for CKD

CooperSurgical Inc ART Media - Procedural steps and scientific information after initial consultation

Origio - Procedural steps and scientific information after initial consultation

Human medicines European public assessment report (EPAR): Irbesartan Teva, irbesartan, Hypertension, Date of authorisation: 30/10/2009, Revision: 16, Status: Authorised

Frequently asked questions about parallel distribution

Flurbiprofen : List of nationally authorised medicinal products - PSUSA/00001450/202211

Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Ovarian Neoplasms;Sarcoma, Kaposi;Multiple Myeloma, Date of authorisation: 31/05/2022, Revision: 2, Status: Authorised